Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley T Crooke

Showing results (1-10 of 122) with videos related to

Pageof 13
Sort By:
Current Molecular Medicine|July 23, 2004
Antisense strategiesStanley T Crooke
Progress in Molecular Biology and Translational Science|August 25, 2022
Progress in molecular biology and translational science addressing the needs of nano-rare patientsStanley T Crooke
Nucleic Acids Research|July 8, 2022
Establishing an environment in which rigorous scientific inquiry is practiced: a personal journeyStanley T Crooke
Nucleic Acid Therapeutics|January 13, 2017
Molecular Mechanisms of Antisense OligonucleotidesStanley T Crooke
Annual Review of Medicine|January 30, 2004
Progress in antisense technologyStanley T Crooke
Nucleic Acid Therapeutics|September 23, 2024
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function MutationsStanley T Crooke
Trends in Molecular Medicine|January 10, 2022
Meeting the needs of patients with ultrarare diseasesStanley T Crooke
Nucleic Acid Therapeutics|January 29, 2025
Addressing the Needs of Nano-Rare PatientsStanley T Crooke
Nucleic Acid Therapeutics|December 8, 2025
<i>Letter:</i> Correspondence on Damle, S.S., <i>et al.</i> (2025) A Workflow for Transcriptome-Wide Assessment of Antisense Oligonucleotide Selectivity. Nucleic Acid TherapeuticsStanley T Crooke
Nature Biotechnology|June 5, 2021
A call to arms against ultra-rare diseasesStanley T Crooke
Pageof 13

Showing results (1-10 of 122) with videos related to

Sort By:
Pageof 13
Current Molecular Medicine|July 23, 2004
Antisense strategiesStanley T Crooke
Progress in Molecular Biology and Translational Science|August 25, 2022
Progress in molecular biology and translational science addressing the needs of nano-rare patientsStanley T Crooke
Nucleic Acids Research|July 8, 2022
Establishing an environment in which rigorous scientific inquiry is practiced: a personal journeyStanley T Crooke
Nucleic Acid Therapeutics|January 13, 2017
Molecular Mechanisms of Antisense OligonucleotidesStanley T Crooke
Annual Review of Medicine|January 30, 2004
Progress in antisense technologyStanley T Crooke
Nucleic Acid Therapeutics|September 23, 2024
Addressing the Challenges of Treating Patients with Heterozygous Gain of Function MutationsStanley T Crooke
Trends in Molecular Medicine|January 10, 2022
Meeting the needs of patients with ultrarare diseasesStanley T Crooke
Nucleic Acid Therapeutics|January 29, 2025
Addressing the Needs of Nano-Rare PatientsStanley T Crooke
Nucleic Acid Therapeutics|December 8, 2025
<i>Letter:</i> Correspondence on Damle, S.S., <i>et al.</i> (2025) A Workflow for Transcriptome-Wide Assessment of Antisense Oligonucleotide Selectivity. Nucleic Acid TherapeuticsStanley T Crooke
Nature Biotechnology|June 5, 2021
A call to arms against ultra-rare diseasesStanley T Crooke
Pageof 13